Expression of Bone Morphogenetic Proteins in Human Metastatic Prostate and Breast Cancer

Bobinac, Dragica; Marić, Ivana; Zoričić, Sanja; Španjol, Josip; Ɖorƌević, Gordana; Mustać, Elvira; Fučkar, Željko
June 2005
Croatian Medical Journal;2005, Vol. 46 Issue 3, p389
Academic Journal
Aim To analyze the expression of bone morphogenetic proteins (BMPs) in prostate and breast cancers with established metastasis in bone, where prostate cancer causes osteoblastic metastases, and breast cancer osteolytic metastases. Methods Primary tumor specimens from 20 patients with prostate cancer and 15 with breast cancer were studied for BMP-2/4, -3, -5, -6 and -7 immunohistochemistry. All patients had multiple bone metastases proven by bone scan. We also examined BMPs expression in normal prostate and breast tissues. BMPs expression was compared with clinicopathological and biochemical parameters. Results Cytoplasmic BMPs immunostaining was observed in both prostate cancer and normal prostate tissue. Expression of BMP-2/4, -5, -6, and -7 proteins was detected in all normal prostate samples, with the predominance of BMP-2/4 (87.8 ± 11.4% positive cells) and BMP-7 (94.6 ± 0.9% positive cells). In prostate cancer tissues, we found variable expression of all BMPs. BMP-2/4 (83 ± 11.6% positive cells) was predominantly expressed in prostate carcinoma, whereas the expression of BMP-7 (24.3 ± 19.2% positive cells) was significantly lower than in the normal prostate. In all breast cancers tissues, we found nu-clear staining only for BMP-7. In normal breast tissue, the BMP expression was not detectable. The percent of BMP-7 positive cells in breast cancer (86.4 ± 7.3%) was higher than in prostatic cancer. Comparing BMP expression levels and clinicopathological parameters, we did not find statistical difference, except for serum alkaline phosphatase, which was significantly higher in patients with prostate cancer. Conclusion The expression of BMPs differs between prostate and breast cancer cells. Identifying the BMP proteins in cancers may be useful for monitoring the tumor status with reference to metastases.


Related Articles

  • Escaping inhibition. Kirkpatrick, Peter // Nature Reviews Drug Discovery;Feb2007, Vol. 6 Issue 2, p111 

    The article discusses research being done on the reason behind the limited efficacy of small-molecule inhibitors of human epidermal growth factor receptor (HER) family kinases in HER2-driven breast cancers. It references a study by N. V. Sergina and colleagues, published in the January 7, 2007...

  • Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis? Buijs, Jeroen T.; Petersen, Maj; van der Horst, Geertje; van der Pluijm, Gabri // Current Pharmaceutical Design;4/11/2010, Vol. 16 Issue 11, p1291 

    Breast and prostate cancer are osteotropic cancers, i.e., carcinomas that have a special predilection to form bone metastases. At postmortem examination, ~70% of patients dying of these cancers have evidence of metastatic bone disease. Bone Morphogenetic Proteins (BMPs) were first identified by...

  • Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1. Tao Qiu; Grizzle, William E.; Oelschlager, Denise K.; Xing Shen; Xu Cao // EMBO Journal;1/24/2007, Vol. 26 Issue 2, p346 

    Alterations in the signaling pathways of bone morphogenetic proteins (BMPs) and activation of the ERK/MAP kinase (MAPK) pathway by growth factors have been implicated in the development and progression of prostate cancer. Smad1 acts as a substrate for MAPKs and also performs a central role in...

  • Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8. Shola, D T N; Wang, H; Wahdan-Alaswad, R; Danielpour, D // Oncogene;5/10/2012, Vol. 31 Issue 19, p2480 

    Hydrogen peroxide-inducible clone-5 (Hic-5, or androgen receptor-associated protein 55) is a transforming growth factor-β-inducible LIM protein whose deregulation is implicated in the progression of prostate cancer. Here, we report that Hic-5 binds to Smads 1, 5 and 8, and represses bone...

  • BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Ren, Wei; Sun, Xiaoxiao; Wang, Ke; Feng, Honglei; Liu, Yuehong; Fei, Chang; Wan, Shaoheng; Wang, Wei; Luo, Jinyong; Shi, Qiong; Tang, Min; Zuo, Guowei; Weng, Yaguang; He, Tongchuan; Zhang, Yan // Molecular Biology Reports;Mar2014, Vol. 41 Issue 3, p1373 

    Bone morphogenetic proteins (BMPs), which belong to the transforming growth factor-β superfamily, regulate a wide range of cellular responses including cell proliferation, differentiation, adhesion, migration, and apoptosis. BMP9, the latest BMP to be discovered, is reportedly expressed in a...

  • BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231. Wang, Ke; Feng, Honglei; Ren, Wei; Sun, Xiaoxiao; Luo, Jinyong; Tang, Min; Zhou, Lan; Weng, Yaguang; He, Tong-Chuan; Zhang, Yan // Journal of Cancer Research & Clinical Oncology;Nov2011, Vol. 137 Issue 11, p1687 

    Background: Transforming growth factor-β (TGF-β) is known to promote tumor proliferation, migration, invasion, and metastasis. Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily. Several BMPs (BMP2 and BMP7) can enhance the invasion and bone metastasis of breast...

  • Bone Morphogenetic Proteins Stimulate Mammary Fibroblasts to Promote Mammary Carcinoma Cell Invasion. Owens, Philip; Polikowsky, Hannah; Pickup, Michael W.; Gorska, Agnieszka E.; Jovanovic, Bojana; Shaw, Aubie K.; Novitskiy, Sergey V.; Hong, Charles C.; Moses, Harold L. // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Bone Morphogenetic Proteins (BMPs) are secreted cytokines that are part of the Transforming Growth Factor β (TGFβ) superfamily. BMPs have been shown to be highly expressed in human breast cancers, and loss of BMP signaling in mammary carcinomas has been shown to accelerate metastases....

  • The Balance of Cell Surface and Soluble Type III TGF-β Receptor Regulates BMP Signaling in Normal and Cancerous Mammary Epithelial Cells. Gatza, Catherine E.; Elderbroom, Jennifer L.; Sun Young Oh; Starr, Mark D.; Nixon, Andrew B.; Blobe, Gerard C. // Neoplasia;Jun2014, Vol. 16 Issue 6, p489 

    Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily that are over-expressed in breast cancer, with context dependent effects on breast cancer pathogenesis. The type III TGF-β receptor (TβRIII) mediates BMP signaling. While TβRIII expression is lost during breast...

  • The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Buijs, J T; van der Horst, G; van den Hoogen, C; Cheung, H; de Rooij, B; Kroon, J; Petersen, M; van Overveld, P G M; Pelger, R C M; van der Pluijm, G // Oncogene;4/26/2012, Vol. 31 Issue 17, p2164 

    Accumulating evidence suggests that a subpopulation of breast cancer cells, referred to as cancer stem cells (CSCs), have the ability to propagate a tumor and potentially seed new metastases. Furthermore, stimulation of an epithelial-to-mesenchymal transition by factors like transforming growth...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics